Compare Tanah Laut Tbk (INDX) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tanah Laut Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Tanah Laut Tbk trades at Rp60 (market cap 26.27B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 4× Tanah Laut Tbk's market cap. Which is the better fit depends on your goals.
| INDX | SCPI | |
|---|---|---|
Market Cap | 26.27B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tanah Laut Tbk
PT Tanah Laut Tbk formerly PT Indoexchange Tbk (the Company) was established under the name PT Sanggrahamas Dipta based on Notarial Deed No.78 dated September 19, 1991 of Rahmah Arie Sutarjo, S.H., notary in Jakarta. The Company changed its status from Foreign Capital Investment Company to Domestic Capital Investment Company, approved by the Chairman of Capital Investment Coordinating Board in accordance with Approval Letter No. 38/V/PMDN/2008 dated September 23, 2008.
Read more on INDX →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
